You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LBH589

Showing 1 - 25 of 122
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)

Completed
Has Results
  • Melanoma
  • Skin Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 18, 2023

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Buffalo, New York
  • +1 more
Aug 11, 2022

MDS (MDS) Trial in United States (Panobinostat)

Terminated
Has Results
  • Myelodysplastic Syndromes (MDS)
  • Fort Myers, Florida
  • +6 more
Nov 18, 2021

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +20 more
  • Scottsdale, Arizona
  • +1 more
May 6, 2022

Renal Cell Carcinoma Trial in United States (LBH589)

Completed
Has Results
  • Renal Cell Carcinoma
  • LBH589
  • Fort Myers, Florida
  • +9 more
Oct 26, 2021

Sickle Cell Disease Trial in Augusta (panobinostat)

Active, not recruiting
  • Sickle Cell Disease
  • Augusta, Georgia
    Augusta University
May 26, 2021

GVHD, GVHD Trial in Tampa (Panobinostat, Sirolimus, Tacrolimus)

Completed
Has Results
  • Graft Versus Host Disease
  • GVHD
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jul 19, 2021

Chronic Myeloid Leukemia in Chronic Phase Trial in Belgium, Germany (LBH589)

Terminated
Has Results
  • Chronic Myeloid Leukemia in Chronic Phase
  • LBH589
  • Bruxelles, Belgium
  • +9 more
Jul 14, 2021

Waldenstrom's Macroglobulinemia Trial in Denver, Boston (LBH589)

Completed
Has Results
  • Waldenstrom's Macroglobulinemia
  • LBH589
  • Denver, Colorado
  • +1 more
Jan 10, 2021

Hepatocellular Carcinoma Trial in Erlangen (Sorafenib + LBH589)

Terminated
  • Hepatocellular Carcinoma
  • Sorafenib + LBH589
  • Erlangen, Germany
    Department of Medicine 1, University Hospital Erlangen
Dec 10, 2020

Non-Hodgkin Lymphoma, Tumors Trial in Las Vegas, Rotterdam (LBH589)

Completed
  • Non-Hodgkin Lymphoma
  • Neoplasms
  • LBH589
  • Las Vegas, Nevada
  • +1 more
Dec 16, 2020

Cancer, Advanced Solid Tumor Trial in Aichi prefecture, Hokkaido, Hyogo prefecture (LBH589)

Completed
  • Cancer
  • Advanced Solid Tumor
  • LBH589
  • Aichi prefecture, Japan
  • +2 more
Dec 16, 2020

NSCLC, Mesothelioma Trial in Canada, United States (LBH589)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Mesothelioma
  • LBH589
  • Fayetteville, Arkansas
  • +4 more
Dec 16, 2020

Cutaneous T-Cell Lymphoma Trial in United States (Panobinostat)

Terminated
Has Results
  • Cutaneous T-Cell Lymphoma
  • Birmingham, Alabama
  • +17 more
Aug 16, 2021

Hormone Refractory Prostate Cancer Trial in United States (LBH589)

Terminated
  • Hormone Refractory Prostate Cancer
  • LBH589
  • Boston, Massachusetts
  • +4 more
Dec 16, 2020

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (Carfilzomib, Chemosensitivity Assay,

Terminated
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 6, 2022

Lymphoma, Leukemia, Multiple Myeloma Trial in Australia, Germany, United States (LBH589)

Completed
Has Results
  • Lymphoma
  • +2 more
  • LBH589
  • Augusta, Georgia
  • +6 more
Dec 16, 2020

Cancer Trial in Sweden, Switzerland, United States (LBH589)

Completed
  • Cancer
  • LBH589
  • Los Angeles, California
  • +8 more
Dec 16, 2020

Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)

Terminated
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +8 more
Jul 9, 2021

Acute Myeloid Leukemia Trial in France, Germany (panobinostat/LBH589B)

Completed
  • Acute Myeloid Leukemia
  • Paris Cedex 4, France
  • +5 more
Dec 16, 2020

Prostate Cancer Trial in Canada, United States (LBH589 (i.v. panobinostat))

Completed
  • Prostate Cancer
  • LBH589 (i.v. panobinostat)
  • Rockville, Maryland
  • +8 more
Dec 16, 2020

Multiple Myeloma Trial in Worldwide (LBH589, Lenalidomide)

Completed
  • Multiple Myeloma
  • LBH589
  • Lenalidomide
  • San Francisco, California
  • +9 more
Dec 16, 2020

Multiple Myeloma Trial in Germany, United States (LBH589)

Terminated
Has Results
  • Multiple Myeloma
  • LBH589
  • Scottsdale, Arizona
  • +28 more
Jun 22, 2021

MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML) Trial in Japan (Panobinostat)

Completed
  • Myelodysplastic Syndromes (MDS)
  • +2 more
  • Nagoya-city, Aichi, Japan
  • +5 more
Dec 16, 2020

Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Trial in

Completed
  • Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma
  • PDR001
  • +5 more
  • Santa Monica, California
  • +24 more
Mar 11, 2022